^
Association details:
Biomarker:No biomarker
Cancer:Ovarian Cancer
Drug:cisplatin (DNA synthesis inhibitor) +
gemcitabine (DNA synthesis inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Acceptable Recurrence Therapies for Epithelial Ovarian (including LCOC) /Fallopian Tube/Primary Peritoneal Cancer...Recurrence Therapy for Platinum-Sensitive Disease...Preferred Regimens...cisplatin/gemcitabine